German utility RWE has won EU antitrust approval to buy the renewables businesses and nuclear electricity generation assets of E.ON, the European Commission said on Tuesday, February 26.
“The Commission concluded that the transaction would raise no competition concerns in the European Economic Area,” an EU executive said in a statement.
On completion, RWE, Germany’s biggest electricity producer, will become Europe’s third-largest renewable energy provider behind Spain’s Iberdrola and Italy’s Enel.
The Bundeskartellamt also cleared the planned acquisition of a minority stake of 16.67% in E.ON by RWE. The planned acquisition is part of an extensive exchange of business activities between the two undertakings. The Bundeskartellamt’s decision comes at the same time as the clearance by the European Commission of the planned acquisition of E.ON assets by RWE. The European Commission’s examination of the acquisition of a majority stake in and control over Innogy by E.ON is still ongoing.
The part of the overall transaction to be examined by the Bundeskartellamt mainly concerns the market for the generation and first time sale of electricity, e.g. to wholesalers, distributors, and large industrial customers, but not the sale of electricity to final consumers.
Andreas Mundt, President of the Bundeskartellamt stated: “We have thoroughly examined the effects of the planned shareholding of RWE in E.ON of 16.67% in cooperation with the European Commission. No competition concerns arise as regards the generation and the first time sale of electricity. RWE is by far the leading supplier in the conventional power generation sector in Germany. This part of the transaction, however, only has a minimal effect on RWE’s market position.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas